The Beatson West of Scotland Cancer Centre   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Glasgow United Kingdom (1886)

Organization Overview

First Clinical Trial
2007
NCT00498407
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Beaston West of Scotland Cancer Centre | The Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow

Active Ingredients

Drugs in Phase 2 Trials (1)

elacytarabine (1 trial)

Drugs in Phase 1 Trials (2)

cannabidiol (Epidiolex) (1 trial)

cremophor (1 trial)

Drugs in Other Trials (1)

ibuprofen (motrin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 2)

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 4